The US government has been emphasizing research and manufacturing in the US in the field of biotechnology, including biopharmaceuticals.
This seems to be due to a sense of crisis that the reliance on China in particular has increased due to the overseas relocation of production facilities in related fields.
President Joe Biden signed an executive order for the National Biotechnology and Biomanufacturing Initiative, the White House said on the 12th (local time).
By allowing everything invented in the United States to be made in the United States in the field of biotechnology, the White House said it will help create jobs in the United States, build strong supply chains and reduce prices.
The White House will hold a meeting on the 14th to announce a wide range of new investments and resources that will shape the executive order signed today.
The White House said that the global industry is a turning point in the industrial revolution based on biotechnology. said to threaten access to
Bloomberg said the move is aimed at increasing U.S. bio-production and reducing reliance on China.
The White House stressed that the bioeconomy is our strength and a huge opportunity given America's industry and strong research firm.
"By harnessing the potential of biotechnology and bioproduction, we will recognize the potential of biology to create almost everything we use in our daily lives, from pharmaceuticals to food," he said.
The White House stressed that it will lead the development of bio-manufacturing that replaces weak overseas supply chains with strong domestic supply chains based on high-paying jobs across the United States.
(Photo = Getty Images Korea)